merLIX™ (marine DNA & nucleotide complex — InnoVactiv)

Clupea harengus (Atlantic herring) milt
Evidence Level
Limited
4 Clinical Trials
4 Documented Benefits
2/5 Evidence Score

merLIX™ is a branded marine bioactive complex from InnoVactiv, made by upcycling sustainably sourced North Atlantic herring milt (soft roe). It is positioned as one of nature's richest sources of marine DNA and nucleotides, and also supplies arginine-rich peptides, polyamines, phospholipids, and omega-3 fatty acids. The brand markets it for everyday cellular vitality, healthy aging, energy metabolism, physical performance, and normal immune function. Honesty note: there are no published human clinical trials on merLIX itself. The rationale rests on broader human research into dietary nucleotides, so the ingredient-specific evidence is preliminary and the studies below used nucleotides in general, not this branded product.

Studied Dose Brand serving guidance ~200-400 mg/day; no human trials on merLIX itself. General nucleotide RCTs used ~50 mg/day to 1.2 g/day.
Active Compound Marine DNA and free nucleotides; with arginine-rich peptides, polyamines, phospholipids, and omega-3 fatty acids.

Benefits

Supports normal immune function

Dietary nucleotides are conditionally important building blocks for rapidly dividing cells, including those of the immune system. In healthy adults, supplemental nucleotides have been shown to support markers of immune readiness, such as immunoglobulin A and natural killer cell activity. As a concentrated marine source of DNA and nucleotides, merLIX is positioned to help maintain everyday immune resilience.

Helps support energy and physical performance

Nucleotides contribute to the cellular energy currency (ATP) and to the rapid tissue turnover that exercise demands. In small studies of physically active people, supplemental nucleotides supported endurance capacity and helped blunt the temporary dip in immune markers that can follow hard exercise. merLIX supplies these same nucleotide building blocks to help support energy metabolism and active recovery.

Supports cellular vitality and healthy aging

The body's demand for nucleotides can rise with age and physiological stress, when the diet may not supply enough. Research on supplemental nucleotides in older adults links higher intake to better-maintained muscle function, body composition, and cellular aging markers. As a dense dietary source of marine nucleotides, merLIX is marketed to help maintain cellular vitality through the aging process.

Provides marine bioactive nutrients

Beyond nucleotides, herring milt naturally contains arginine-rich peptides, polyamines, membrane phospholipids, and omega-3 fatty acids. This combination of marine bioactives is the basis for merLIX being offered as a multifunctional, food-derived complex rather than a single isolated compound.

Mechanism of action

1

Dietary nucleotide supply for cell turnover

Although the body can synthesize nucleotides, the salvage pathway and dietary intake become important for tissues with high turnover, such as gut lining and immune cells. Supplying preformed nucleotides may spare the metabolic cost of de novo synthesis and support nucleic acid production during rapid cell division.

2

Contribution to cellular energy substrates

Nucleotides such as adenine-based species are precursors to ATP and other nucleotide cofactors that drive cellular energy metabolism and signaling. Increasing the available pool of these substrates is the proposed basis for nucleotide effects on energy and exercise endurance.

3

Marine bioactive matrix

Herring milt delivers nucleotides alongside arginine-rich peptides, polyamines, phospholipids, and omega-3 fatty acids. These co-factors are biologically active in their own right, so the proposed benefit is attributed to the combined marine matrix rather than to nucleotides alone.

Clinical trials

1
Nucleotides and immune response to exercise

Randomized, double-blind, placebo-controlled pilot trial of sublingual nucleotides 50 mg/day for 14 days (Ostojic & Obrenovic 2012, J Int Soc Sports Nutr). Tests nucleotides in general, not merLIX.

38 healthy young men (ages 20-25), regularly exercising.

The nucleotide group showed significantly higher serum immunoglobulin A and natural killer cell cytotoxic activity, and a smaller post-exercise drop in salivary immunoglobulins and lactoferrin, versus placebo. No adverse effects were reported. This is class-level evidence for nucleotides supporting immune markers around exercise, not a test of merLIX.

2
Nucleotides and run time to exhaustion

Randomized, double-blind, placebo-controlled trial of sublingual nucleotides 50 mg/day for 14 days (Ostojic, Idrizovic & Stojanovic 2013, Nutrients). Tests nucleotides in general, not merLIX.

30 healthy, physically active young men (ages 20-25).

Run time to exhaustion improved by roughly 5% in the nucleotide group, with significant increases in serum immunoglobulin A and natural killer cell activity, and no adverse effects. Supports a possible ergogenic and immune role for nucleotides as a class; merLIX was not the product studied.

3
Dietary nucleotides in older adults

Randomized, triple-blind, controlled trial of yeast nucleotides 250 mg/day or a 150 mg/day nucleotide formula over 10 weeks (Gene-Morales et al. 2025, Nutrients). Tests nucleotides in general, not merLIX.

69 independent older adults (ages 60-75).

Both nucleotide groups showed greater gains in executive function and isokinetic strength and better-maintained fat and muscle mass than placebo, which lost muscle and gained fat. Supports nucleotides as a class for healthy aging endpoints; the source and dose differ from merLIX.

4
Nucleotides and biological aging (TALENTs)

19-week, double-blind, randomized, placebo-controlled trial of yeast-derived nucleotides 1.2 g/day (Wang et al. 2025, Adv Sci, TALENTs study). Tests nucleotides in general, not merLIX.

121 community-dwelling older adults (ages 60-70).

The nucleotide group showed a significantly lower DNA-methylation age (about 3 years younger than placebo over 19 weeks), improved insulin sensitivity, modest gains in skeletal muscle mass, and reduced fatigue, with no serious adverse events. The dose far exceeds typical merLIX servings, so this is supportive class evidence only.

Side effects and drug interactions

Common Potential side effects

Generally considered well tolerated; no merLIX-specific safety trials are published, so the long-term safety profile of this branded product is not established in humans.
Derived from herring (fish), so it is unsuitable for people with fish allergy and may carry a fishy taste or aftertaste.
Marine ingredients can occasionally cause mild digestive upset such as nausea or burping, especially at higher servings.
Purine and nucleotide intake may be a consideration for people who are advised to limit purines (for example, those prone to gout); discuss with a clinician.

Important Drug interactions

No specific drug interactions are documented for merLIX; because it supplies omega-3 fatty acids, theoretical additive effects with anticoagulant or antiplatelet medication cannot be ruled out at high intakes.
People managing gout or on urate-lowering therapy should be aware that nucleotides contribute to purine intake and may discuss use with their clinician.
As with any new supplement, those who are pregnant, breastfeeding, or taking prescription medication should consult a healthcare provider before use.

Frequently asked questions about merLIX™ (marine DNA & nucleotide complex — InnoVactiv)

What is merLIX?

merLIX™ is a branded marine bioactive complex from InnoVactiv, made by upcycling sustainably sourced North Atlantic herring milt (soft roe). It is positioned as one of nature's richest sources of marine DNA and nucleotides, and also supplies arginine-rich peptides, polyamines, phospholipids, and omega-3 fatty acids.

What is merLIX used for?

merLIX is researched primarily for Immune Support and Energy. Dietary nucleotides are conditionally important building blocks for rapidly dividing cells, including those of the immune system.

What is the recommended dosage of merLIX?

The clinically studied dose is Brand serving guidance ~200-400 mg/day; no human trials on merLIX itself. General nucleotide RCTs used ~50 mg/day to 1.2 g/day. Always follow the product label and check with a healthcare provider for personal advice.

Is merLIX safe, and does it have side effects?

For most healthy adults, merLIX is well tolerated at studied doses. Reported effects can include: Generally considered well tolerated; no merLIX-specific safety trials are published, so the long-term safety profile of this branded product is not established in humans. It may also interact with some medications. merLIX is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does merLIX interact with any medications?

Possible interactions include: No specific drug interactions are documented for merLIX; because it supplies omega-3 fatty acids, theoretical additive effects with anticoagulant or antiplatelet medication cannot be ruled out at high intakes. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for merLIX?

NutraSmarts rates the evidence for merLIX as Limited (2 out of 5). It is backed by 4 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Ostojic SM, Obrenovic M. Sublingual nucleotides and immune response to exercise. J Int Soc Sports Nutr. 2012;9(1):31. doi: 10.1186/1550-2783-9-31.PubMedUsed to support: CLASS evidence for nucleotides in general (NOT merLIX): 50 mg/day sublingual nucleotides for 14 days raised serum IgA and NK cell cytotoxic activity and reduced post-exercise decline in salivary immunoglobulins/lactoferrin in healthy young men. Backs the 'supports normal immune function' and exercise-immunity benefits.
  2. Ostojic SM, Idrizovic K, Stojanovic MD. Sublingual nucleotides prolong run time to exhaustion in young physically active men. Nutrients. 2013;5(11):4776-4785. doi: 10.3390/nu5114776.PubMedUsed to support: CLASS evidence for nucleotides in general (NOT merLIX): 50 mg/day sublingual nucleotides for 14 days improved run time to exhaustion by ~5% and raised IgA and NK cell activity vs placebo. Backs the 'energy and physical performance' benefit as nucleotide-class, not product-specific.
  3. Gene-Morales J, Juesas A, Saez-Berlanga A, et al. Dietary nucleotides enhance neurogenesis, cognitive capacity, muscle function, and body composition in older adults: a randomized, triple-blind, controlled clinical trial. Nutrients. 2025;17(9):1431. doi: 10.3390/nu17091431.PubMedUsed to support: CLASS evidence for nucleotides in general (NOT merLIX): 250 mg/day yeast nucleotides or a 150 mg/day nucleotide formula over 10 weeks improved executive function and strength and preserved muscle and fat mass in older adults vs placebo. Backs the 'cellular vitality and healthy aging' benefit at the class level; source/dose differ from merLIX.
  4. Wang S, Song L, Fan R, et al. Nucleotides as an anti-aging supplementation in older adults: a randomized controlled trial (TALENTs study). Adv Sci (Weinh). 2025;12(33):2417728. doi: 10.1002/advs.202417728.PubMedUsed to support: CLASS evidence for nucleotides in general (NOT merLIX): 1.2 g/day yeast-derived nucleotides over 19 weeks lowered DNA-methylation age by ~3 years, improved insulin sensitivity, increased skeletal muscle mass, and reduced fatigue vs placebo in older adults. Supports healthy-aging/cellular-vitality framing; dose far exceeds typical merLIX servings.